Nordihydroguaiaretic acid

Short Summary : Anti-tumor agent;lipoxygenase inhibitor

Category : PI3K/Akt/mTOR Signaling|mTOR

Purity : 0.9983

CAS Number : 500-38-9

Formula : C18H22O4

Molecular Weight : 302.36

SMILE : CC(C(CC1=CC(O)=C(O)C=C1)C)CC2=CC(O)=C(O)C=C2

Solubility : 25?: DMSO

Storage : Store at -20°C

Description : Description:
IC50 Value: N/A
Nordihydroguaiaretic acid (NDGA) is a natural phenolic compound isolated from the creosote bush Larrea divaricata, which has anti-tumor activities both in vitro and in vivo. Its analogs are in clinical development for use in refractory solid tumors.
in vitro: NDGA may also direct target mTORC1 complex because NDGA suppressed amino acids- and insulin-stimulated mTORC1 and acted like rapamycin to disrupt mTOR-Raptor interaction [1]. NDGA increased PPAR? promoter activity in AML12 hepatocytes and also prevented the fatty acid suppression of PPAR? expression. In contrast, PPAR? siRNA abrogated the stimulatory effect of NDGA on fatty acidcatabolism [2].
in vivo: NDGA was able to induce Nrf2 translocation in vivo in kidneys of rats submitted to both U-NX and I/R injury and to protect against renal histological damage and apoptosis [3]. Comparison of the proportion of live mice at the age of 90% mortality was used as a surrogate for measurement of maximum lifespan;neither NDGA (p=0.12) nor aspirin (p=0.16) had a significant effect in this test. Measures of blood levels of NDGA or aspirin and its salicylicacid metabolite suggest that the observed lack of effects of NDGA or aspirin on life span in females could be related to gender differences in drug disposition or metabolism [4].
Clinical trial: Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancer . Phase 1

Download datasheet